Skip to content

News

News

12/14/2007 New Biomedical Firm Headquartered at CMU-RC

A biomedical start-up company has joined Central Michigan University Research Corp. in the Mount Pleasant SmartZone. Bauer BioMedical LLC, a firm developing an early detection method for cancer, is the newest high-tech tenant to locate its corporate headquarters in one of the facility's laboratories.

10/24/2007 CMU-RC to Host Grant Proposal Seminar for Start-up Companies

Central Michigan University Research Corporation will host an informational seminar on funding sources for small businesses Nov. 2 from 9 a.m. to noon at the Center for Applied Research and Technology.

9/30/2007 CMU-RC Joins Michigan Health Information Alliance in Leading Mid-Michigan Health Information Exchange Efforts

A new partnership forged by the Central Michigan University Research Corp. will help to create a regional network of health information.

9/24/2007 CMU-RC Consortium Addresses Nanotechnologies as Building Blocks for Medical Breakthroughs

Central Michigan University Research Corp. welcomed experts from across North America to Mount Pleasant last week for a strategic workshop to direct the future of nanotechnology research. The National Science Foundation sponsored the consortium that could lead to advanced technology efforts in facilitating epic medical breakthroughs.

8/13/2007 CMU-RC and Dendritic Nanotechnologies Launch Research to Purify Groundwater

Central Michigan University Research Corporation and Dendritic Nanotechnologies Inc. have developed technology capable of absorbing toxic chemicals from ground water that could lead to a revolutionary ground water purification system.

5/30/2007 CMU Research Laboratories Celebrate Grand Opening

Central Michigan University will celebrate the grand opening of its new research laboratories at the Center for Applied Research and Technology June 7.

2/14/2007 CMU Technology Park Offers Rent Free Space

If you're a researcher with the right stuff, one of Michigan's leading technology incubators has free space in which to explore.

10/26/2006 CMU and Partners Get Funding for New Dendrimer Imaging Technology

Central Michigan University Research Corporation (CMU-RC) has received $810,000 in federal grant funding to develop dendrimer-based imaging technology that can better detect tumors and other ailments.

10/4/2006 Starpharma Acquires DNT

Dendritic Nanotechnologies Inc. (DNT) and Starpharma Holdings Limited (ASX:SPL, USOTC:SPHRY), today signed an agreement for Starpharma to acquire the outstanding equity of U.S.-based DNT for $6.97 million, payable through the issue of Starpharma shares. Starpharma currently owns 33% of DNT, and The Dow Chemical Company is the other major shareholder, with a 30% equity stake.

9/29/2006 DNT Receives NCI Contract to Develop Dendrimer-Based Diagnostic and Therapeutic Delivery System for Ovarian Cancer

Dendritic Nanotechnologies Inc. (DNT) and the National Cancer Institute (NCI) have entered into a Small Business Innovation Research (SBIR) contract valued at $850,000. The project will use DNT's Priostar™ dendrimers to develop a new generation of targeted diagnostic and therapeutic delivery technology for the early detection and treatment of epithelial ovarian cancer. Annual U.S. expenditures for medical treatment of ovarian cancer are approximately $1.5 billion.


View Archive

Designed and created by DDM Marketing & Communications.